AI-powered computational module generating integrated cardiovascular and cerebrovascular risk assessment scores. Combines physiological data interpretation with machine learning to provide comprehensive risk profiling for clinical decision-making.
Manufactured by
South Korea
Harvey Cardio Co., Ltd. – Innovating Cardiovascular Disease Screening Through Precision Technology Havey Cardio is setting a new standard in cardiovascular and cerebrovascular screening through our proprietary Pulse Wave Transit Time Ratio (PWR) analysis technology. 1. Technological Innovation: Unmatched Precision - Traditional Pulse Wave Velocity (PWV) methods often suffer from measurement errors depending on the patient’s body type or the practitioner’s technique. We have overcome these limitations by developing a technology that analyzes pulse wave data based on time ratios alone, eliminating the need for distance measurements. This breakthrough has been clinically validated, achieving a high diagnostic accuracy of approximately 82% in sensitivity and specificity. 2. Practical Innovation: Accessibility and Ease of Use - Equipped with our self-developed, high-sensitivity digital pressure sensors, our solution enables the simultaneous, accurate, and convenient measurement of pulse waves from multiple body points. We provide an environment where cardiovascular health can be managed easily not only in specialized general hospitals but also in primary care clinics, making preventive screening more accessible than ever. 3. Future Innovation: Synergy Between AI and Expertise - Our robust R&D ecosystem is led by executives with extensive experience in the pharmaceutical and healthcare industries, alongside a dedicated team of Ph.D. researchers in biomedical engineering. We are currently advancing a next-generation diagnostic platform that utilizes Artificial Intelligence (AI) simulations to detect subtle anomalies in pulse wave signals. Our Vision: Following our certification as a Venture Business and the official recognition of our Corporate R&D Center in 2025, Harvey Cardio is now poised for a major leap forward. Our mission is clear: to contribute to global health by developing innovative methods for the early detection and prevention of cardiovascular diseases, ensuring a healthier life for all humanity.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Soilt (Yancheng) Intelligent Technology Co.,ltd.
China · 1 relevant product
Ornament Health AG
Switzerland · 1 relevant product
Advanced Medical Solutions s.r.o.
Czech Republic · 4 relevant products
SOT Sonotechnik Austria Angio Experience GmbH
Austria · 1 relevant product
FOOT ADAPT SOLUTIONS S.L.
Spain · 1 relevant product
KARDI AI Technologies s.r.o
Czech Republic · 3 relevant products
Beijing sinotech&wellcare technology and development Co.,Ltd
China · 1 relevant product
AXIS Healthcare Trading FZE
United Arab Emirates · 1 relevant product
Nalong Health Technology Co., Ltd
China · 1 relevant product
LIVGEMINI SRL
Italy · 3 relevant products
40 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →7 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 68 closest product alternatives
Soilt (Yancheng) Intelligent Technology Co.,ltd. · China
An artificial intelligence-based analytical system that processes health screening data to generate personalized health assessments and recommendations. The module synthesizes information from multiple diagnostic inputs for comprehensive health evaluation.
Ornament Health AG · Switzerland
A clinical decision support system that evaluates individual health risks based on habits, goals, and health data. The module recommends appropriate preventive checkups and health interventions tailored to patient profiles.
Advanced Medical Solutions s.r.o. · Czech Republic
Software module for calculating and tracking multiple cardiovascular risk factors in patient populations. Integrates clinical data to identify high-risk individuals requiring vascular screening.
SOT Sonotechnik Austria Angio Experience GmbH · Austria
Software application providing monthly license-based vascular health scoring and assessment capabilities.
FOOT ADAPT SOLUTIONS S.L. · Spain
Machine learning algorithm trained on 400,000+ patient biomechanical datasets for automated analysis of movement patterns and personalized treatment recommendations. Provides predictive risk assessment for movement-related injuries.
KARDI AI Technologies s.r.o · Czech Republic
AI-based computational tool for assessing patient risk of adverse cardiac events. Integrates multiple clinical, imaging, and laboratory parameters to generate personalized risk scores. Supports evidence-based decision-making for patient management and treatment planning.
Beijing sinotech&wellcare technology and development Co.,Ltd · China
An optional module integrated with the chronic disease management platform that provides intelligent clinical decision recommendations. Analyzes patient data to generate diagnostic and therapeutic suggestions aligned with clinical guidelines and institutional protocols.
AXIS Healthcare Trading FZE · United Arab Emirates
AI-powered cardiovascular risk assessment system that analyzes patient data to identify and stratify cardiac risk factors. Integrates clinical parameters and diagnostic indicators to support evidence-based clinical decision-making and preventive cardiology interventions.
Nalong Health Technology Co., Ltd · China
An AI-powered diagnostic platform for cardiac assessment and risk stratification. The system utilizes machine learning algorithms to analyze cardiac parameters and support clinical diagnosis.
KARDI AI Technologies s.r.o · Czech Republic
AI-powered software platform for cardiac imaging analysis and interpretation. Utilizes machine learning algorithms to assist in the detection and classification of cardiovascular abnormalities from medical imaging data. Designed to support clinicians in diagnostic decision-making and patient risk stratification.
LIVGEMINI SRL · Italy
Advanced computational platform combining neural network-based anatomical reconstruction with AI-driven analysis for patient-specific cardiovascular assessment. Supports diagnosis, device selection optimization, and surgical planning with automated feature identification and clinical reporting.
Oxitone Medical Ltd · Israel
AI-based system for analyzing hyper-personalized physiological data and generating clinical insights. Supports care management strategy development and risk mitigation.
56 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products